Insider Trading & Ownership - PASITHEA THERAPEUTICS CORP WT (KTTAW)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for PASITHEA THERAPEUTICS CORP WT
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-06-02
Purchase
2023-06-06
9:00 pm
Pasithea Therapeutics Corp. KTTA STEINMAN LAWRENCE
Director
30,000 $0.431 $12,930 1,327,174
(Direct)
View
2022-10-17
Purchase
2022-10-19
5:29 pm
Pasithea Therapeutics Corp. KTTA Delaney David
Concord IP2 Ltd.
Elderhill Corp
Member of 10% owner group
1,000 $1.11 $1,110 227,521
(Indirect)
View
2022-09-28
Purchase
2022-09-30
4:36 pm
Pasithea Therapeutics Corp. KTTA Shahinian Eric
Camac Capital LLC
Camac Fund LP
Camac Partners LLC
Member of 10% owner group
64,357 $1.1856 $76,299 1,788,415
(Indirect)
View
2022-09-01
Purchase
2022-09-06
5:03 pm
Pasithea Therapeutics Corp. KTTA Shahinian Eric
Camac Capital LLC
Camac Fund LP
Camac Partners LLC
Member of 10% owner group
88,901 $1.129 $100,367 1,724,058
(Indirect)
View
2022-08-29
Purchase
2022-08-31
4:32 pm
Pasithea Therapeutics Corp. KTTA Shahinian Eric
Camac Capital LLC
Camac Fund LP
Camac Partners LLC
Member of 10% owner group
22,828 $1.1518 $26,293 1,635,157
(Indirect)
View
2022-08-19
Purchase
2022-08-26
4:30 pm
Pasithea Therapeutics Corp. KTTA Geller Avi
Leonite Fund I LP
Leonite Capital LLC
Member of 10% owner group
54,644 $1.2982 $70,939 1,089,346
(Indirect)
View
2022-08-17
Purchase
2022-08-18
7:35 pm
Pasithea Therapeutics Corp. KTTA Shahinian Eric
Camac Capital LLC
Camac Fund LP
Camac Partners LLC
Member of 10% owner group
155,773 $1.2087 $188,283 1,611,329
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-12
Option Award
2024-06-14
5:25 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Novak Alfred J
Director
750 $5.61 3,500
(Direct)
View
2024-06-13
Option Award
2024-06-14
5:25 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Novak Alfred J
Director
2,750 $5.62 3,500
(Direct)
View
2024-03-01
Option Award(A)
2024-04-05
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Marques Tiago
Chief Executive Officer
26,669 $0 26,669
(Direct)
View
2024-03-01
Option Award(A)
2024-04-05
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Dumesnil Simon
Director
7,500 $0 7,500
(Direct)
View
2024-03-01
Option Award(A)
2024-04-05
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Schneiderman Daniel H
Chief Financial Officer
15,927 $0 15,927
(Direct)
View
2024-03-01
Option Award(A)
2024-04-05
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Leahy Emer
Director
7,500 $0 7,500
(Direct)
View
2024-03-01
Option Award(A)
2024-04-05
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Novak Alfred J
Director
5,000 $0 5,000
(Direct)
View
2024-03-01
Option Award(A)
2024-04-05
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Currie Graeme Martin
Chief Development Officer
5,938 $0 5,938
(Direct)
View
2024-03-01
Option Award(A)
2024-04-05
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA STEINMAN LAWRENCE
Director
7,500 $0 7,500
(Direct)
View
2024-03-01
Option Award
2024-03-01
9:47 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA STEINMAN LAWRENCE
Director
7,500 $0 7,500
(Direct)
View
2024-03-01
Option Award
2024-03-01
9:46 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Schneiderman Daniel H
Chief Financial Officer
15,927 $0 15,927
(Direct)
View
2024-03-01
Option Award
2024-03-01
9:46 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Novak Alfred J
Director
5,000 $0 5,000
(Direct)
View
2024-03-01
Option Award
2024-03-01
9:46 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Marques Tiago
Chief Executive Officer
26,669 $0 26,669
(Direct)
View
2024-03-01
Option Award
2024-03-01
9:46 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Leahy Emer
Director
7,500 $0 7,500
(Direct)
View
2024-03-01
Option Award
2024-03-01
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Dumesnil Simon
Director
7,500 $0 7,500
(Direct)
View
2024-03-01
Option Award
2024-03-01
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp. KTTA Currie Graeme Martin
Chief Development Officer
5,938 $0 5,938
(Direct)
View

Ownership
2023-07-03
5:00 pm
2023-06-30
2033-02-23
Pasithea Therapeutics Corp. KTTA Currie Graeme Martin
Chief Development Officer
0 $0 300,000
(Direct)
View

Ownership
2023-02-14
6:15 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA PD Joint Holdings LLC Series 2016-A
Manning Paul B
Manning Bradford
Tiger Lily Capital LLC
10% Owner
0 $0 3,408,696
(Direct)
View
2022-11-28
Option Award
2022-11-28
4:00 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA STEINMAN LAWRENCE
Director
5,000 $0.98 1,287,174
(Direct)
View
2022-11-23
Option Award
2022-11-28
4:00 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Marques Tiago
Chief Executive Officer
5,000 $1 819,206
(Direct)
View
2022-11-23
Option Award
2022-11-28
4:00 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Marques Tiago
Chief Executive Officer
1,206 $1.02 819,206
(Direct)
View
2022-11-23
Option Award
2022-11-28
4:00 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Marques Tiago
Chief Executive Officer
3,000 $1.03 819,206
(Direct)
View
2022-11-22
Option Award
2022-11-22
4:10 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA STEINMAN LAWRENCE
Director
5,000 $0.99 1,282,174
(Direct)
View
2022-11-17
Option Award
2022-11-17
4:34 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Dumesnil Simon
Director
40,000 $1.06 150,000
(Direct)
View
2022-11-15
Option Award
2022-11-17
4:34 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Dumesnil Simon
Director
10,000 $1.07 150,000
(Direct)
View
2021-08-02
Option Award
2022-11-17
4:34 pm
2022-08-02
2031-08-02
Pasithea Therapeutics Corp. KTTA Dumesnil Simon
Director
100,000 $0 150,000
(Direct)
View
2022-10-26
Option Award
2022-10-26
5:35 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA STEINMAN LAWRENCE
Director
5,000 $1.1 1,277,174
(Direct)
View
2022-10-21
Option Award
2022-10-24
10:15 am
2023-10-21
2032-10-21
Pasithea Therapeutics Corp. KTTA Novak Alfred J
Director
100,000 $0 100,000
(Direct)
View
2022-10-21
Option Award
2022-10-21
5:05 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Marques Tiago
Chief Executive Officer
4,400 $1.07 810,000
(Direct)
View
2022-10-21
Option Award
2022-10-21
5:05 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Marques Tiago
Chief Executive Officer
600 $1.08 810,000
(Direct)
View
2022-10-17
Option Award
2022-10-17
6:11 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA STEINMAN LAWRENCE
Director
9,000 $1.13 1,272,174
(Direct)
View
2022-10-17
Option Award
2022-10-17
6:11 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA STEINMAN LAWRENCE
Director
1,000 $1.14 1,272,174
(Direct)
View
2022-10-11
Option Award
2022-10-12
8:15 pm
2023-10-11
2032-10-11
Pasithea Therapeutics Corp. KTTA Schneiderman Daniel H
Chief Financial Officer
300,000 $0 300,000
(Direct)
View

Ownership
2022-08-16
5:56 pm
N/A
N/A
Pasithea Therapeutics Corp. KTTA Delaney David
Concord IP2 Ltd.
Elderhill Corp
Member of 10% owner group
0 $0 226,521
(Indirect)
View

Ownership
2022-08-15
06:13 am
N/A
N/A
Pasithea Therapeutics Corp. KTTA Shahinian Eric
Camac Capital LLC
Camac Fund LP
Camac Partners LLC
Member of 10% owner group
0 $0 1,455,556
(Indirect)
View

Ownership
2022-08-15
06:12 am
N/A
N/A
Pasithea Therapeutics Corp. KTTA Geller Avi
Leonite Capital LLC
Member of 10% owner group
10% Owner
0 $0 1,034,702
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next